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Abstract
Background: Increasing evidence suggests that ABPM more closely predicts target organ damage
than does clinic measurement. Future guidelines may suggest ABPM as routine in the diagnosis and
monitoring of hypertension. This would create difficulties as this test is expensive and often difficult
to obtain. The purpose of this study is to determine the degree to which the BpTRU automatic
blood pressure monitor predicts results on 24 hour ambulatory blood pressure monitoring
(ABPM).
Methods: A quantitative analysis comparing blood pressure measured by the BpTRU device with
the mean daytime blood pressure on 24 hour ABPM. The study was conducted by the Centre for
Studies in Primary Care, Queen's University, Kingston, Ontario, Canada on adult primary care
patients who are enrolled in two randomized controlled trials on hypertension. The main
outcomes were the mean of the blood pressures measured at the three most recent office visits,
the initial measurement on the BpTRU-100, the mean of the five measurements on the BpTRU
monitor, and the daytime average on 24 hour ABPM.
Results: The group mean of the three charted clinic measured blood pressures (150.8 (SD10.26)
/ 82.9 (SD 8.44)) was not statistically different from the group mean of the initial reading on BpTRU
(150.0 (SD21.33) / 83.3 (SD12.00)). The group mean of the average of five BpTRU readings (140.0
(SD17.71) / 79.8 (SD 10.46)) was not statistically different from the 24 hour daytime mean on
ABPM (141.5 (SD 13.25) / 79.7 (SD 7.79)). Within patients, BpTRU average correlated significantly
better with daytime ambulatory pressure than did clinic averages (BpTRU r = 0.571, clinic r =
0.145). Based on assessment of sensitivity and specificity at different cut-points, it is suggested that
the initial treatment target using the BpTRU be set at <135/85 mmHG, but achievement of target
should be confirmed using 24 hour ABPM.
Conclusion: The BpTRU average better predicts ABPM than does the average of the blood
pressures recorded on the patient chart from the three most recent visits. The BpTRU automatic
clinic blood pressure monitor should be used as an adjunct to ABPM to effectively diagnose and
monitor hypertension.
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Background
Hypertension is a continuous, independent, yet modifia-
ble risk factor for cardiovascular, cerebrovascular and
renal disease. It has been estimated that 62% of cerebrov-
ascular disease and 49% of ischemic heart disease can be
attributed to suboptimal blood pressure(BP) control [1].
Since 24 hour ambulatory blood pressure monitoring
(ABPM) is currently recommended as the measurement of
choice in difficult cases (uncertainty of diagnoses, fluctu-
ating office visits, unresponsiveness to treatment, white
coat affect(WCE)) [1-5] it is, in effect, the 'final arbiter' or
'gold standard' for the diagnosis of hypertension and the
assessment of whether target has been achieved. The gen-
erally accepted blood pressure target on ABPM is a day-
time average pressure of < 135/85 mmHG [2-4]; the target
blood pressure when measured in the doctors office is <
140/90 mmHG.
Increasing evidence suggests that ABPM more closely pre-
dicts target organ damage than does clinic measurement.
The Ohsama study found that cardiovascular mortality,
but not all cause mortality, was more closely predicted by
the daytime systolic blood pressure than clinic pressures
[6]. ABPM also better predicted cardiovascular events such
as MI, CHF, stroke and TIA [4,5] as well as other target
organ damage such as ventricular hypertrophy, proteinu-
ria, plasma creatinine, and stroke [5,7-14].
Many patients have clinically significant WCE, making
clinic measurements an unreliable indicator of true blood
pressure control [11]. Future guidelines may suggest
ABPM as routine in the diagnosis and monitoring of
hypertension. This would create difficulties as this test is
expensive and often difficult to obtain.
Recently, automatic blood pressure measuring devices
have been used either at home or in the clinic setting [16].
It has been found that the measurements taken at home,
or while not in the presence of clinic staff, have a better
correlation with daytime ABPM than do nurse or physi-
cian measurements [15-17]. Home or clinic self measure-
ment is also preferred by patients over 24 hour
monitoring [18].
The purpose of this study is to determine the possible clin-
ical utility of the BpTRU automated blood pressure mon-
itor in the diagnosis and monitoring of hypertension in
the primary care clinic setting. Specifically, we set out i) to
determine how BpTRU measurements related to ABPM
measurements and ii) to determine the level of BpTRU
measurement that best predicted a mean daytime blood
pressure of <135 mmHG systolic and < 85 mmHG diasto-
lic. The BpTRU monitor has been developed by VSM
MedTech Ltd of Vancouver Canada specifically for the cli-
nician's office.
Methods
The data used in this study is a subset of the data collected
for two ongoing RCTs being conducted at the Centre for
Studies in Primary Care at Queen's University, Kingston,
Ontario, Canada – the Home Monitoring of Blood Pres-
sure Study (ISRCTN25105161) and the Intensive Sched-
uled Management of Hypertension Study
(ISRCTN05874865) which are funded by the Heart and
Stroke Foundation of Ontario. A group of 481 subjects for
which all relevant data were available were used for anal-
yses of correlations.
Subjects were recruited from 51 family practices in eastern
Ontario. All patients with a diagnosis of hypertension
who were being treated with antihypertensive medica-
tions were identified in each practice. Each patient's chart
was reviewed to abstract the blood pressures recorded on
the patient's chart at the last three office visits where blood
pressure was measured. Only one recording was used
from any single office visit. If there was more than one
recording at a given visit, the last measurement recorded
for that visit was used. These visits ranged from several
weeks to several months apart, depending on the practice
of the physician regarding follow-up of hypertensive
patients. If the mean of these three readings, taken at dif-
ferent visits, was ≥ 140/90, the patient was labeled as
'uncontrolled' by office measurement, meaning that the
patient had not achieved the treatment target (≥ 130/80
was used for diabetics). The research nurse then contacted
these uncontrolled patients and invited them to partici-
pate in the study. Subjects were excluded if they were <18
years of age, pregnant, or had a known secondary cause
for their hypertension.
BpTRU measurements
The BpTRU device uses the oscillometric technique used
by most ambulatory and home blood pressure measuring
devices [19,20]. It is designed to take an initial reading
while the clinician is present, and then with the patient
alone in the room, proceeds to take 5 more measurements
at intervals of 1–5 minutes and then provides an average
of these five readings.
The specific steps we used were: i) the subjects were seated
for at least 5 minutes, ii) the BpTRU cuff was applied to
the non-dominant arm by the research nurse, iii) the ini-
tial BpTRU blood pressure reading was taken and
recorded, iv) the staff then left the room while the BpTRU
device took a minimum further 5 readings at intervals of
either one minute or two minutes, v) these five readings
were averaged by the device and this average was
recorded. The BpTRU device has passed the standards ofBMC Cardiovascular Disorders 2005, 5:18 http://www.biomedcentral.com/1471-2261/5/18
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the British Hypertension Society and the Association of
Advancement of Medical Instrumentation [20,21].
Ambulatory monitoring
All patients then had ABPM monitoring using oscillomet-
ric A&D Model TM2430 equipment (A&D Medical, Milpi-
tas, California, USA). The ABPM equipment was applied
at the same visit as the other research measurements. The
cuff was fixed to the non-dominant arm and the device
was set to obtain automatic readings every 15 minutes
during the day (0600–2200) and every 30 minutes at
night (2200–0600). This monitoring took place on work-
ing days and subjects were instructed to behave and work
as usual. The A&D Model TM2430 has been clinically val-
idated according to the British Hypertension Society pro-
tocols [22].
Results
Of the 481 subjects, 210 (43.6 %) were male and 271
(56.3 %) female. The average age was 64.9 (SD 11.59)
with a range of 33 to 92 and average BMI was 30.6 (SD
5.22). All but 2 subjects were on antihypertensive medica-
tions. In essence, this was a population of treated known
hypertensive patients.
Comparison of group mean blood pressures
Table 1 shows the mean and standard deviations(SD) of
systolic and diastolic BP as measured in the family physi-
cians' offices (the average of the blood pressure measure-
ments recorded on the patient chart at the last three
visits), the initial BpTRU reading, the average BpTRU read-
ing, and the 24 hour daytime average. There was no statis-
tical difference in group mean between clinic
measurement and initial BpTRU readings, and no statisti-
cal difference between average BpTRU readings and ABPM
daytime average.
Comparison of BP target achievement
A large proportion of those subjects who had uncon-
trolled hypertension according to the mean of the three
last clinic BPs had lower blood pressure on either or both
of BpTRU or 24 hour monitor. In 393 (81.7%) of the 481
subjects the systolic blood pressure was less with the
BpTRU than with the clinic readings and in 312 (64.8%)
of the 481 subjects the systolic blood pressure was less
with daytime ABPM than with the clinic readings. Diasto-
lic pressure similarly decreased in 332 (69.0%) using the
BpTRU average and 292 (60.7%) with daytime ABPM. In
all, 250 of the 470 (53.2%) were found by BpTRU moni-
tor to have achieved the accepted clinic measurement tar-
get of <140/90 mmHG. ABPM revealed that 162 subjects
(33.4%) were actually normotensive with a daytime aver-
age of <135/85 mmHG.
Correlations
Pearson correlations (Table 2) were calculated comparing
the mean daytime systolic and diastolic ABPM results with
the average of the blood pressure measurements recorded
on the patient's office chart, the first BpTRU measurement
taken in the presence of the staff, and with the average of
five readings on the BpTRU device.
Using BpTRU to predict achievement of targets
ABPM is accepted as the most reliable way to determine if
blood pressure targets are achieved in hypertensive
patients, but using ABPM after every medication
adjustment is impractical and costly. To determine which
level of BpTRU blood pressure best predicted achievement
of target (i.e. <135/85) on ABPM, various prediction esti-
mates (sensitivity, specificity, and predictive values) were
calculated for different levels of BpTRU readings (Tables 3
and 4).
Table 1: Mean systolic and diastolic BPs
Average of the blood pressures measured at the last three office visits 150.8 (SD10.26) / 82.9 (SD 8.44)
BpTRU initial reading 150.0 (SD21.33) / 83.3 (SD12.00)
BpTRU Average 140.0 (SD17.71) / 79.8 (SD 10.46)
24 hour daytime average 141.5 (SD 13.25) / 79.7 (SD 7.79)
Table 2: Pearson Correlation coefficients
Mean 24 hr daytime systolic Mean 24 hr daytime diastolic
Mean of the blood pressure measurements at the last three office visits r = 0.145 r = 0.316
1st BpTRU measurement r = 0.473 r = 0.554
Average BpTRU(out of 5) r = 0.571 r = 0.610BMC Cardiovascular Disorders 2005, 5:18 http://www.biomedcentral.com/1471-2261/5/18
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Discussion
The measurements of blood pressure done with a provider
present, that is the mean of the physician office measure-
ments, and the observed first BpTRU measurements were
not significantly different from each other and probably
are both affected by the white coat phenomenon. This
also suggests that the mean of the last three office blood
pressure measurements is a good proxy for the patient's
current blood pressure, taken with a health care
professional present (an observed blood pressure meas-
urement). Both of these measures, that is, the mean of the
last three office blood pressures and the first, observed
reading from the BpTRU, were significantly higher than
multiple measurements taken when a provider is not
present, that is the mean of the five BpTRU measurements
and the daytime mean on ABPM. The mean of the BpTRU
and the daytime mean on ABPM were not significantly
different.
Recommended BpTRU Thresholds
Our data suggest that the degree of agreement between the
BpTRU and 24 hour ABPM is not sufficient for clinicians
to use BpTRU alone to determine if BP targets have been
achieved. However, since the agreement between the
BpTRU and ABPM is so much better than the usual sphyg-
momanometer-based, observed, clinic measures, it seems
reasonable to use the BpTRU to make treatment adjust-
ment decisions to a predetermined BpTRU level and then
confirm it with a 24 hour ABPM. If one considers Table 3,
it would seem that a systolic BP level of <135 mmHG pro-
vides the best overall agreement with the 24 hour ABPM.
Similarly, for the diastolic two-by-two tables in Table 4,
Table 3: Two-By-Two Tables And BpTRU Predictive Characteristics For Achievement Of ABPM Systolic Target
Systolic Target Achieved on 
ABPM (<135 mmHG mean 
daytime blood pressure)
Yes NO
< 140 mmHG on BpTRU Yes 131 137 Sens = 80%; Spec = 55% PPV = 49%; NPV = 84%
No 32 170
< 135 mmHG on BpTRU Yes 111 101 Sens = 68%; Spec = 67% PPV = 52%; NPV = 80%
No 52 206
< 130 mmHG on BpTRU Yes 86 59 Sens = 53%; Spec = 81% PPV = 59%; NPV = 76%
No 77 248
< 125 mmHG on BpTRU Yes 62 31 Sens = 39%; Spec = 90% PPV = 67%; NPV = 73%
No 101 276
< 120 mmHG on BpTRU Yes 42 12 Sens = 26%; Spec = 96% PPV = 78%; NPV = 71%
No 121 295
Table 4: Two-by-Two Tables and BpTRU predictive characteristics for achievement of ABPM diastolic target
Diastolic Target Achieved on 
ABPM (<85 mmHG mean 
daytime blood pressure)
Yes NO
< 90 mmHG on BpTRU Yes 341 58 Sens = 92%; Spec = 43% PPV = 86%; NPV = 61%
No 28 43
< 85 mmHG on BpTRU Yes 299 36 Sens = 81%; Spec = 64% PPV = 89%; NPV = 48%
No 70 65
< 80 mmHG on BpTRU Yes 238 13 Sens = 65%; Spec = 87% PPV = 95%; NPV = 40%
No 131 88
< 75 mmHG on BpTRU Yes 161 5 Sens = 44%; Spec = 95% PPV = 97%; NPV = 32%
No 208 96
< 70 mmHG on BpTRU Yes 82 1 Sens = 22%; Spec = 99% PPV = 99%; NPV = 26%
No 287 100BMC Cardiovascular Disorders 2005, 5:18 http://www.biomedcentral.com/1471-2261/5/18
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one would likely choose <85 mmHG diastolic as the most
appropriate BpTRU level for diastolic pressure.
Clinicians should consider treating patients to a level of
<135/85 mmHG using the BpTRU or similar automated
multiple reading device, and at that point conduct a 24
hour ABPM to confirm that a daytime mean pressure of
<135/85 mmHG has been achieved. If it has not been
achieved, the clinician should further treat to a BpTRU
level of <130/80 mmHG or <125/75 mmHG before re-
assessing with 24 hour ABPM.
Limitations
Our data are the best currently available to provide some
sense of what a BP target level should be when using the
BpTRU in office practice. However there are some limita-
tions. The BpTRU and ABPM were carried out in a research
setting not a true clinical setting. All the patients had
uncontrolled blood pressure according to office BP meas-
urements, so it does not represent a full spectrum; it does
not include normotensive patients or patients where the
chart records suggest target has been achieved. The data
was collected in the course of another study. There is a
need for a study that sets out, a priori, to compared BpTRU
with ABPM in the full spectrum of patients, and which fol-
lows those patients for a longer term to assess clinical
outcomes.
Conclusion
The control of hypertension is vital to decrease cardiovas-
cular morbidity and mortality, however the current rec-
ommended BP targets are often not being met. There is
also growing evidence that office measured sphygmoma-
nometer-based blood pressures are unreliable and do not
predict outcomes as well as ABPM, whereas there is
increasing evidence from prospective trials that 24 hour
monitoring has prognostic significance. We have shown
that the BpTRU has potential to be used in the clinic set-
ting to help overcome the difficulties caused by the WCE
without the cost of having to conduct frequent 24 hour
ABPMs.
Although this study demonstrates that the BpTRU has a
sensitivity and specificity that are not ideal when
compared to the ABPM device we used, it is superior to
usual office measurement and can be used by clinicians as
part of their strategy for determining whether BP target
has been achieved. We suggest that the BpTRU be used to
adjust treatment until patient's BpTRU pressure is below
135/85 mmHg and then a 24 hour ABPM be conducted to
confirm. ABPM measurement is not practical as a means
of monitoring targets after each medication adjustment
but in conjunction with the BpTRU can form the basis for
clinical decisions that will promote more effective control
of hypertension.
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